---
trial_id: 667
discovery_date: 2022-04-15 12:12:54.188898
date: 2022-04-15 12:12:54.188898
title: "A Single-arm, Open-label, Phase II Study of Sabatolimab in Combination With Azacitidine and Venetoclax in Adult Participants With High or Very High Risk Myelodysplastic Syndromes (MDS) as Per IPSS-R Criteria"
summary: |
  
link: 'https://www.novartis.com//clinicaltrials/study/nct04812548'
published_date: NaT
trial_source: Novartis
relevant: 
options:
  unlisted: false
---
